Aeglea Biothera (NQ: AGLE )

7.820 USD +0.070 (+0.90%)

Official Closing Price Updated: 4:01 PM EST, Mar 3, 2021 Add to My Watchlist

Price and Volume

Volume	340,700
Open	7.750
Bid (Size)	7.820 (153)
Ask (Size)	7.860 (16)
Prev. Close	7.750
Today's Range	7.730 - 8.170
52wk Range	3.500 - 11.38
Shares Outstanding	21,858,874
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Aeglea BioTherapeutics Appoints Sara Brownstein to Board of Directors

February 24, 2021

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today...

Aeglea BioTherapeutics Announces Transition of Chief Financial Officer

February 03, 2021

Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company developing a new generation of human enzyme therapeutics as innovative solutions for rare metabolic diseases, today...

Performance

YTD	-8.64%	-8.64%
1 Month	+7.27%	+7.27%
3 Month	-5.78%	-5.78%
6 Month	+4.69%	+4.69%
1 Year	+21.62%	+21.62%

More News

Aeglea BioTherapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

January 04, 2021

Aeglea BioTherapeutics Appoints Alison Lawton to Board of Directors

December 17, 2020

Aeglea BioTherapeutics Receives FDA Rare Pediatric Disease Designation for ACN00177 for the Treatment of Homocystinuria

December 01, 2020

Aeglea BioTherapeutics Announces New Presentation Time at Upcoming Investor Conference

November 24, 2020

Aeglea BioTherapeutics to Participate in Two Upcoming Virtual Investor Conferences

November 17, 2020

Aeglea BioTherapeutics Reports Third Quarter 2020 Financial Results and Corporate Highlights

November 05, 2020

Aeglea BioTherapeutics Announces U.S. and EU Orphan Drug Designations for ACN00177 for the Treatment of Homocystinuria

October 26, 2020

Aeglea BioTherapeutics Announces Presentations on Arginase 1 Deficiency and Homocystinuria Programs at Two Upcoming Virtual Medical Meetings

October 05, 2020

Aeglea BioTherapeutics to Participate in September Investment Conferences

September 02, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.